Omnicell (OMCL) Current Deferred Revenue (2013 - 2026)
Omnicell's (OMCL) quarterly Current Deferred Revenue came in at $247.9 million in Q2 2026, up 5.92% year-over-year from $234.0 million in Q2 2025, and down 9.84% quarter-over-quarter from $275.0 million in Q1 2026.
Analysis
Omnicell (OMCL) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Current Deferred Revenue for 14 consecutive years, with $247.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Deferred Revenue rose 5.92% year-over-year to $247.9 million in Q2 2026; TTM through Jun 2026 was $247.9 million, a 5.92% increase from a year earlier, with the FY2025 full-year figure at $235.1 million, up 8.1% from the prior year.
- Current Deferred Revenue was $247.9 million for Q2 2026 at Omnicell, down from $275.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $275.0 million in Q1 2026 and troughed at $132.8 million in Q2 2022.
- A 5-year average of $204.0 million and a median of $217.9 million in 2024 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue dropped 0.31% in 2022 and surged 30.57% in 2023, its largest moves.
- Over 5 years, Current Deferred Revenue stood at $156.3 million in 2022, then rose by 15.37% to $180.4 million in 2023, then grew by 20.59% to $217.5 million in 2024, then advanced by 8.1% to $235.1 million in 2025, then rose by 5.43% to $247.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $247.9 million (Q2 2026), $275.0 million (Q1 2026), and $235.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247.89 Mn |
| Mar 31, 2026 | 274.96 Mn |
| Dec 31, 2025 | 235.12 Mn |
| Sep 30, 2025 | 245.50 Mn |
| Jun 30, 2025 | 234.04 Mn |
| Mar 31, 2025 | 238.37 Mn |
| Dec 31, 2024 | 217.49 Mn |
| Sep 30, 2024 | 222.18 Mn |
| Jun 30, 2024 | 218.25 Mn |
| Mar 31, 2024 | 229.78 Mn |
| Dec 31, 2023 | 180.36 Mn |
| Sep 30, 2023 | 180.04 Mn |
| Jun 30, 2023 | 173.35 Mn |
| Mar 31, 2023 | 185.74 Mn |
| Dec 31, 2022 | 156.33 Mn |
| Sep 30, 2022 | 148.44 Mn |
| Jun 30, 2022 | 132.77 Mn |
| Mar 31, 2022 | 152.04 Mn |
| Dec 31, 2021 | 132.40 Mn |
| Sep 30, 2021 | 128.87 Mn |